A clinical trial to evaluate the performance and safety of the wekebere system for monitoring fetal wellbeing during labor
Phase 2
Not yet recruiting
- Conditions
- Pregnancy and Childbirth
- Registration Number
- PACTR202311817720428
- Lead Sponsor
- Vilgro Africa
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 120
Inclusion Criteria
i.Female age between: 18-50
ii.Gestational age >36 + 0 weeks
iii.Singleton pregnancy
iv.Early labour (cervical dilatation of <6cm)
v.Sign informed consent
Exclusion Criteria
i.Female age between: 18-50
ii.Gestational age >36 + 0 weeks
iii.Singleton pregnancy
iv.Early labour (cervical dilatation of <6cm)
v.Sign informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie fetal wellbeing monitoring using the Wekebere system in labor?
How does the Wekebere system compare to standard electronic fetal monitoring in detecting fetal distress?
Are there specific biomarkers that enhance the accuracy of the Wekebere system for high-risk pregnancies?
What adverse events are associated with the Wekebere system during labor monitoring and how are they managed?
What are the potential advantages of the Wekebere system over existing fetal monitoring technologies in low-resource settings?